FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' norepinephrine bitartrate as an original application (generic) product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Hypotension
• Septic Shock

Drugs mentioned

• Norepinephrine bitartrate (Norepinephrine bitartrate)

Snippet

ORIG AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)